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Reimbursement changes from the Centers for Medicare and Medicaid and 
value-based purchasing systems have made quality improvements linked 
to clinical outcomes more crucial than ever. Reimbursement for care related 
to hospital-acquired complications is not provided. Value-based purchasing 
programs reward good clinical outcomes and efficient health care practices 
with higher reimbursement rates. The Affordable Care Act enforces the 
necessity of improving care and reducing costs in federal and private 
health insurance programs. In one neurocritical care unit, various providers 
and nurses collaborated to address key infection parameters that impact 
patient outcomes in an attempt to improve overall healthcare practices and 
decrease mortality. 
Improving Clinical Outcomes in a Neurocritical Intensive Care Unit Through Collaboration        
and Innovation
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 •  Urinary catheter use has decreased by more than 10 % with a subsequent decrease in CAUTIs by 80% 
(p-value < 0.0001).
 •  CVC use decreased by 5% with 60% decrease in CLABSI (p-value < 0.45) 
 •  Total ventilator days decreased by 1000 vent days per year. No incidence of ventilator-associated 
pneumonia over study period
 •  Number of patients with serum glucose within institutional goal of 70-180 mg/dl increased from 82.08% 
(FY2015) to 89% (FY2017)
 •  Observed/Expected mortality improved by 4.4%
The intensive care unit is an expanding component of healthcare, accounting for approximately 82 
billion US healthcare dollars. Thus, there is motivation for providers to reduce costs and improve 
patient outcomes. One neurocritical care unit achieved this by initiating simple measures such as 
daily multi-disciplinary rounds to determine patient needs. A new ventilator mode, ASV, was also 
implemented to better prepare patients for extubation. This not only decreased total ventilator 
days, but also prevented reintubation and as a result, no ventilator-associated pneumonias were 
recorded over the study period. Furthermore, staff accountability was increased by making unit 
performance data visible to patients and their families as well as integrating these quality metrics 
into performance evaluations. These methods ultimately resulted in earlier discontinuation of 
healthcare devices leading to a decrease in total device days. Though device utilization did not 
significantly decrease during the study period, the results show that optimization of variables such 
as infection control, temperature management, glycemic control, and ventilator strategies can have 
an overall positive impact on patient mortality and morbidity.
As evidenced by these results, this institution is now a top performer when compared in a 
national clinical database. The quality initiatives discussed improved the overall observed/
expected mortality ratio by 4.4%. This study presents pragmatic strategies that can be used in any 
neurocritical care unit or patient care organization to create a culture of quality improvement.  
CONCLUSION
Bringing evidence-based medicine to the bedside in the form of protocols, 
guidelines, and practices. 
 •  Practicing daily collaborative rounds with a team consisting of a 
neurointensivist, nurse, physician assistant, physical therapist, occupational 
therapist, nutritionist, pharmacist, and case manager.
 •  Using Adaptive Support Ventilation (ASV) mode for earlier vent weaning.
 •  Maintaining glucose levels below 80 mg/dl more than 85% of the time.
 •  Implementing a normothermia protocol in conjunction with bromocriptine 
administration.
 •  Displaying visible posters throughout the unit that outline quality data to 
raise awareness of performance.
 •  Integrating quality metrics into annual evaluation of all staff to ensure 
accountability.
All data points were collected from electronic surveillance systems.
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Figure 1: Device Utilization in a 
Neurocritical Care Unit
METHODS

























Device Utilization in a Neurocritical Care Unit 














































Device-associated Infections in relation to glycemic control
CAUTI CLABSI VAPs Glucose 70 - 180 (%)
Figure 3: Expected and Observed Mortality in a Neurocritical Care Unit
